Monday Dec 7 | Mid-Hudson News
Pharmaceutical company to expand Westchester operations
GREENBURGH Regeneron Pharmaceuticals will expand its presence in Westchester County by adding a third building to its research facility at the Landmark at Eastwood campus in Greenburgh.
Regeneron to add jobs at East Greenbush facility
Drug company Regeneron Pharmaceuticals has announced a $40 million investment projected to create more than 300 jobs in New York state, including up to 100 in Rensselaer County.
Regeneron adding 50 to 100 jobs in East Greenbush
Tarrytown-based Regeneron Pharmaceuticals Inc. is embarking on a major expansion following a collaboration agreement reached last month with Paris-based sanofi-aventis, in which sanofi-aventis will provide up to $160 million annually for Regeneron antibody research from 2010 to 2017.
Regeneron plans $40M expansion, adding 400 jobs
Regeneron Pharmaceuticals Inc. is investing $40 million in an expansion that will create up to 100 jobs in East Greenbush and anotheer 300 jobs at its Westchester County campus.
BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals...
BioMed Realty Trust, Inc. announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc.
X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor
Howard Hughes Medical Institute, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA Present address: Regeneron Pharmaceuticals, Inc., Protein Chemistry Sciences, 777 Old Saw Mill River Road, Tarrytown, New York 10591, USA.
4 Platform Drugmakers to Invest In
Platforms aren't just for acrobatic moves before splashing into the pool or '70s night at the disco.
Sanofi Expands Regeneron Agreement
Analyst Report ) recently extended and expanded its antibody collaboration with biopharmaceutical company, Regeneron Pharmaceuticals, Inc.
Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity'
Chris Viehbacher, CEO of Sanofi-Aventis , said his company will establish a venture capital fund, joining an ever-growing queue of pharma venture capital funds seeking to gain better access biotech innovation.
Stock Smackdown: Cramer vs. CAPS
There's no denying that Mad Money host Jim Cramer is entertaining, popular, and passionate .
Big Pharma Willing to Pay for Biotech Innovation
If the past week is any indication, big pharma is showing that it is willing to pay for biotech innovation.
Filed under: Motorola , Research in Motion , Palm Inc This was a strange day with a half-participation as bonds and many government offices were closed due to this being the Veterans Day holiday.
Drug Companies Should Think Smaller
"Betting the farm and waiting for the next blockbuster is not going to work," sanofi-aventis CEO Christopher Viehbacher told Forbes Magazine in its most recent issue .
Now That's What I Call a Drug Deal
Investors are regenerating their interest in Regeneron Pharmaceuticals after it extended its drug-discovery pact with sanofi-aventis . The 19% overnight gain has certainly gotten my attention .
'Mad Money Lightning Round': American Express Clicks
Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Monday evening.
Regeneron Pharmaceuticals Inc. Reports Operating Results
Regeneron Pharmaceuticals Inc. filed Quarterly Report for the period ended 2009-09-30. Regeneron Pharmaceuticals Inc.
Customer Interaction Solutions
CTL, REGN, ROCK, LZB, ALX, WSC Expected To Be Higher Leading Up To Next Earnings Releases
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and November earnings reports.
Attracting More Biotech Companies
Westchester has been aiming to attract biotech companies for years, and the expansion of Regeneron in Tarrytown into a new, $112-million, state-of-the-art laboratory complex in Tarrytown, as well as OSI Pharmaceuticals' move from Long Island to Ardsley, mark major successes for the county.
Westchester Slowly Lures Biotech Companies
After more than six years of courting the biotech industry, Westchester County is getting some positive results.
Sanofi-Merrimack deal keeps trend alive
Our oncology M&A list keeps growing. Sanofi-Aventis SA , which is already on it, is acquiring the rights to sell an experimental cancer treatment developed by Merrimack Pharmaceuticals Inc.
Also on Topix